NCT01795768View on ClinicalTrials.gov

Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

PHASE2UnknownINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2015

Conditions

Gastric CancerOesophageal CancerBreast CancerSquamous Cell Carcinoma of the Lung

Interventions

DRUG

AZD 4547

Trial Locations (1)

SM2 5PT

RECRUITING

Royal Marsden NHS Foundation Trust, London and Surrey

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Royal Marsden NHS Foundation Trust

OTHER